Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Udelson

Circulation

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Circulation|September 21, 2011
T.M.I. (Too much information)?James E Udelson
Circulation|November 23, 2011
Heart failure with preserved ejection fractionJames E Udelson
Circulation|February 5, 2019
Evaluating and Reducing the Risk of Sudden Death in Hypertrophic CardiomyopathyJames E Udelson
Circulation|June 22, 2016
The Future of Heart Failure Diagnosis, Therapy, and ManagementJames E Udelson, Lynne Warner Stevenson
Circulation|August 15, 2022
Glucose-Insulin-Potassium Therapy for Acute Myocardial Infarction: 50 Years On and Time for a RelookJames E Udelson, Harry P Selker, Eugene Braunwald
Circulation|July 23, 2008
Arginine vasopressin antagonists for the treatment of heart failure and hyponatremiaJohn J Finley, Marvin A Konstam, James E Udelson
Circulation|December 2, 2015
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of CardiologyRobert O Bonow, Rick A Nishimura, Paul D Thompson, et al.
Circulation|December 2, 2015
Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of CardiologyPaul D Thompson, Robert J Myerburg, Benjamin D Levine, et al.
Circulation|June 20, 2003
Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathyBarry J Maron, N A Mark Estes, Martin S Maron, et al.
Circulation|September 28, 2005
Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemiaVasken Dilsizian, Timothy M Bateman, Steven R Bergmann, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Circulation|September 21, 2011
T.M.I. (Too much information)?James E Udelson
Circulation|November 23, 2011
Heart failure with preserved ejection fractionJames E Udelson
Circulation|February 5, 2019
Evaluating and Reducing the Risk of Sudden Death in Hypertrophic CardiomyopathyJames E Udelson
Circulation|June 22, 2016
The Future of Heart Failure Diagnosis, Therapy, and ManagementJames E Udelson, Lynne Warner Stevenson
Circulation|August 15, 2022
Glucose-Insulin-Potassium Therapy for Acute Myocardial Infarction: 50 Years On and Time for a RelookJames E Udelson, Harry P Selker, Eugene Braunwald
Circulation|July 23, 2008
Arginine vasopressin antagonists for the treatment of heart failure and hyponatremiaJohn J Finley, Marvin A Konstam, James E Udelson
Circulation|December 2, 2015
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of CardiologyRobert O Bonow, Rick A Nishimura, Paul D Thompson, et al.
Circulation|December 2, 2015
Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of CardiologyPaul D Thompson, Robert J Myerburg, Benjamin D Levine, et al.
Circulation|June 20, 2003
Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathyBarry J Maron, N A Mark Estes, Martin S Maron, et al.
Circulation|September 28, 2005
Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemiaVasken Dilsizian, Timothy M Bateman, Steven R Bergmann, et al.
Pageof 3